Bain Capital Life Sciences Investors, LLC Insider Trades

Insider Trading History

Track insider trading activity for Bain Capital Life Sciences Investors, LLC. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rapid Micro Biosystems
Rapid Micro Biosystems RPID
10% owner
Holding Value $2.47M 1,463,000 shares
Last Trade
May 20, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.82M 4,389,000 shares
$2.01
$1.69
Solid Biosciences
Solid Biosciences SLDB
10% owner
Holding Value $56.6M 6,444,170 shares
Last Trade
Feb 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.47M 1,000,000 shares
$6.47
$8.79
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
10% owner
Holding Value $36.9M 3,500,000 shares
Last Trade
Jan 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$17.6M 3,500,000 shares
$5.04
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
10% owner
Holding Value $45.3M 4,300,000 shares
Last Trade
Jan 10, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$17.6M 3,500,000 shares
$5.04
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
10% owner
Holding Value $82.1M 7,800,000 shares
Last Trade
Jan 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.73M 300,000 shares
$5.76
$10.53
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
10% owner
Holding Value $51.3M 1,632,653 shares
Last Trade
Dec 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.3M 1,632,653 shares
$24.69
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
10% owner
Holding Value $30.5M 1,632,653 shares
Last Trade
Dec 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.3M 1,632,653 shares
$13.02
$18.70
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
10% owner
Holding Value $0 0 shares
Last Trade
Dec 04, 2024 Sale
$45.5M 4,513,216 shares
$10.09
$10.53
Kyverna Therapeutics
Kyverna Therapeutics KYTX
10% owner
Holding Value $0 0 shares
Last Trade
Feb 07, 2024 Sale
No data
No data
$8.43
Solid Biosciences
Solid Biosciences SLDB
10% owner
Holding Value $35.5M 4,034,582 shares
Last Trade
Jan 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.96M 904,160 shares
$7.70
$8.79
Annexon
Annexon ANNX
10% owner
Holding Value $30.1M 5,701,926 shares
Last Trade
May 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$639k 300,000 shares
$2.13
$5.28
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
10% owner
Holding Value $0 0 shares
Last Trade
Dec 22, 2022 Sale
$75k 100,000 shares
$0.75
$18.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
10% owner
Holding Value $0 0 shares
Last Trade
Dec 22, 2022 Sale
$1.15M 100,000 shares
$11.50
$31.40
Annexon
Annexon ANNX
10% owner
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale
$3.03M 774,943 shares
$3.91
$5.28
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $25M 2,805,413 shares
Last Trade
Dec 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$241k 25,000 shares
$9.65
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $24.7M 2,780,413 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$39.5k 4,011 shares
$9.84
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $24.7M 2,776,402 shares
Last Trade
Dec 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$129k 13,458 shares
$9.62
$8.90
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $227M 4,831,307 shares
Last Trade
Aug 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.3M 1,000,000 shares
$70.25
$46.99
Rapid Micro Biosystems
Rapid Micro Biosystems RPID
10% owner
Holding Value $0 0 shares
Last Trade
Jul 19, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$135M 6,672,819 shares
$20.20
$1.69
Rapid Micro Biosystems
Rapid Micro Biosystems RPID
10% owner
Holding Value $14.3M 8,434,560 shares
Last Trade
Jul 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2M 100,000 shares
$20.00
$1.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up